Bay Street News, January, 2019

Includes first 5G device Doubles the number of devices accepted by customers announced at the beginning of 2018 GOLETA, Calif., […]

SAN DIEGO and TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company […]

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will […]

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the dosing of the […]

NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

PLEASANTON, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release […]

LOS ANGELES, Jan. 02, 2019 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) today responded to a document published by […]

SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on […]

ENGLEWOOD CLIFFS, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company […]

– 50 mg Cohort Completed – – Clinical Update Expected in the Second Quarter of 2019 – SOUTH SAN FRANCISCO, […]